Page last updated: 2024-09-03

sk&f 104976 and 5,22-cholestadien-3beta-ol

sk&f 104976 has been researched along with 5,22-cholestadien-3beta-ol in 1 studies

Compound Research Comparison

Studies
(sk&f 104976)
Trials
(sk&f 104976)
Recent Studies (post-2010)
(sk&f 104976)
Studies
(5,22-cholestadien-3beta-ol)
Trials
(5,22-cholestadien-3beta-ol)
Recent Studies (post-2010) (5,22-cholestadien-3beta-ol)
1001801

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busto, R; Cano, S; Dávalos, A; de la Peña, G; Giera, M; Herrera, E; Lasunción, MA; Sánchez-Wandelmer, J1

Other Studies

1 other study(ies) available for sk&f 104976 and 5,22-cholestadien-3beta-ol

ArticleYear
Inhibition of cholesterol biosynthesis disrupts lipid raft/caveolae and affects insulin receptor activation in 3T3-L1 preadipocytes.
    Biochimica et biophysica acta, 2009, Volume: 1788, Issue:9

    Topics: 3T3-L1 Cells; Animals; Caveolae; Caveolin 1; Cell Membrane; Cholesterol; Dehydrocholesterols; Enzyme Inhibitors; G(M1) Ganglioside; Lanosterol; Membrane Microdomains; Mice; Receptor, Insulin; trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride; Triparanol

2009